Hurthle Cell Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer (NCT04544111) | Memorial Sloan Kettering Cancer Center | 2020-09-02 |
Track Hurthle Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.